La maladie de Parkinson en France (serveur d'exploration) - Checkpoint (PubMed)

Index « Auteurs » - entrée « J M Senard »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
J M Reymann < J M Senard < J M Shoffner  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 38.
[0-20] [0 - 20][0 - 38][20-37][20-40]
Ident.Authors (with country if any)Title
000F31 (2004) P. Pollak [France] ; F. Tison ; O. Rascol ; A. Destée ; J J Péré ; J M Senard ; F. Durif ; I. BourdeixClozapine in drug induced psychosis in Parkinson's disease: a randomised, placebo controlled study with open follow up.
001123 (2001) J M Senard [France] ; C. Brefel-Courbon ; O. Rascol ; J L MontastrucOrthostatic hypotension in patients with Parkinson's disease: pathophysiology and management.
001128 (2001) J L Montastruc [France] ; K. Desboeuf ; M. Lapeyre-Mestre ; J M Senard ; O. Rascol ; C. Brefel-CourbonLong-term mortality results of the randomized controlled study comparing bromocriptine to which levodopa was later added with levodopa alone in previously untreated patients with Parkinson's disease.
001239 (1999) J L Montastruc [France] ; O. Rascol ; J M SenardTreatment of Parkinson's disease should begin with a dopamine agonist.
001346 (1998) J L Montastruc [France] ; M. Pelat ; P. Verwaerde ; C. Brefel-Courbon ; M A Tran ; O. Blin ; O. Rascol ; J M SenardFluoxetine in orthostatic hypotension of Parkinson's disease: a clinical and experimental pilot study.
001354 (1998) O. Rascol [France] ; U. Sabatini ; C. Brefel ; N. Fabre ; S. Rai ; J M Senard ; P. Celsis ; G. Viallard ; J L Montastruc ; F. CholletCortical motor overactivation in parkinsonian patients with L-dopa-induced peak-dose dyskinesia.
001372 (1997) O. Rascol [France] ; U. Sabatini ; N. Fabre ; C. Brefel ; I. Loubinoux ; P. Celsis ; J M Senard ; J L Montastruc ; F. CholletThe ipsilateral cerebellar hemisphere is overactive during hand movements in akinetic parkinsonian patients.
001384 (1997) J M Senard [France] ; S. Raï ; M. Lapeyre-Mestre ; C. Brefel ; O. Rascol ; A. Rascol ; J L MontastrucPrevalence of orthostatic hypotension in Parkinson's disease.
001401 (1997) J L Montastruc [France] ; O. Rascol ; J M SenardGlutamate antagonists and Parkinson's disease: a review of clinical data.
001418 (1997) N. Andreu [France] ; C. Damase-Michel ; J M Senard ; O. Rascol ; J L MontastrucA dose-ranging study of selegiline in patients with Parkinson's disease: effect of platelet monoamine oxidase activity.
001429 (1996) O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; J L Montastruc ; D. FuellRopinirole in the treatment of levodopa-induced motor fluctuations in patients with Parkinson's disease.
001435 (1996) J L Montastruc [France] ; O. Rascol ; J M SenardNew directions in the drug treatment of Parkinson's disease.
001462 (1996) J L Montastruc [France] ; J M Senard ; O. Rascol ; A. RascolAutonomic nervous system dysfunction and adrenoceptor regulation in Parkinson's disease. Clinical and pharmacological consequences.
001467 (1996) M E Llau [France] ; G. Durrieu ; M A Tran ; J M Senard ; O. Rascol ; J L MontastrucA study of dopaminergic sensitivity in Parkinson's disease: comparison in "de novo" and levodopa-treated patients.
001468 (1996) O. Rascol [France] ; A J Lees ; J M Senard ; Z. Pirtosek ; C. Brefel ; J L Montastruc ; D. FuellA placebo-controlled study of ropinirole, a new D2 agonist, in the treatment of motor fluctuations of L-DOPA-treated parkinsonian patients.
001472 (1995) J L Montastruc [France] ; O. Rascol ; J M Senard ; G. Houin ; A. RascolSublingual apomorphine: a new pharmacological approach in Parkinson's disease?
001506 (1995) O. Rascol [France] ; U. Sabatini ; N. Fabre ; J M Senard ; M. Simonetta-Moreau ; J L Montastruc ; M. Clanet ; A. RascolAbnormal vestibuloocular reflex cancellation in multiple system atrophy and progressive supranuclear palsy but not in Parkinson's disease.
001511 (1994) M E Llau [France] ; L. Nguyen ; J M Senard ; O. Rascol ; J L Montastruc[Drug-induced parkinsonian syndromes: a 10-year experience at a regional center of pharmaco-vigilance].
001517 (1994) M. Galinier [France] ; J M Senard ; P. Valet ; J P Doazan ; G. Durrieu ; M A Tran ; J L Monstastruc ; J P BounhoureRelationship between arterial blood pressure disturbances and alpha adrenoceptor density.
001522 (1994) O. Rascol [France] ; U. Sabatini ; F. Chollet ; N. Fabre ; J M Senard ; J L Montastruc ; P. Celsis ; J P Marc-Vergnes ; A. RascolNormal activation of the supplementary motor area in patients with Parkinson's disease undergoing long-term treatment with levodopa.
001524 (1994) O. Rascol [France] ; N. Fabre ; O. Blin ; J. Poulik ; U. Sabatini ; J M Senard ; M. Ané ; J L Montastruc ; A. RascolNaltrexone, an opiate antagonist, fails to modify motor symptoms in patients with Parkinson's disease.

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/ParkinsonFranceV1/Data/PubMed/Checkpoint
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i -k "J M Senard" 
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Checkpoint/Author.i  \
                -Sk "J M Senard" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    ParkinsonFranceV1
   |flux=    PubMed
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Author.i
   |clé=    J M Senard
}}

Wicri

This area was generated with Dilib version V0.6.29.
Data generation: Wed May 17 19:46:39 2017. Site generation: Mon Mar 4 15:48:15 2024